These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10761000)

  • 1. Can angiotensin-converting enzyme inhibitors protect against symptomatic radiation pneumonitis?
    Wang LW; Fu XL; Clough R; Sibley G; Fan M; Bentel GC; Marks LB; Anscher MS
    Radiat Res; 2000 Apr; 153(4):405-10. PubMed ID: 10761000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-Angiotensin System Inhibitors Might Help to Reduce the Development of Symptomatic Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.
    Bracci S; Valeriani M; Agolli L; De Sanctis V; Maurizi Enrici R; Osti MF
    Clin Lung Cancer; 2016 May; 17(3):189-97. PubMed ID: 26427647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.
    Harder EM; Park HS; Nath SK; Mancini BR; Decker RH
    Pract Radiat Oncol; 2015; 5(6):e643-9. PubMed ID: 26412341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.
    Wang H; Liao Z; Zhuang Y; Xu T; Nguyen QN; Levy LB; O'Reilly M; Gold KA; Gomez DR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1071-7. PubMed ID: 24161424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Risk of Radiation Pneumonitis With Coincident Concurrent Use of Angiotensin-converting Enzyme Inhibitors in Patients Receiving Lung Stereotactic Body Radiation Therapy.
    Alite F; Balasubramanian N; Adams W; Surucu M; Mescioglu I; Harkenrider MM
    Am J Clin Oncol; 2018 Jun; 41(6):576-580. PubMed ID: 27560156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker.
    Molteni A; Moulder JE; Cohen EF; Ward WF; Fish BL; Taylor JM; Wolfe LF; Brizio-Molteni L; Veno P
    Int J Radiat Biol; 2000 Apr; 76(4):523-32. PubMed ID: 10815633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic radiation pneumonitis in elderly patients receiving thoracic irradiation.
    Kharofa J; Gore E
    Clin Lung Cancer; 2013 May; 14(3):283-7. PubMed ID: 23291257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic ACE-Inhibition Mitigates Radiation-Induced Pneumonitis by Suppressing ACE-Expressing Lung Myeloid Cells.
    Sharma GP; Fish BL; Frei AC; Narayanan J; Gasperetti T; Scholler D; Pierce L; Szalewski N; Blue N; Medhora M; Himburg HA
    Int J Radiat Oncol Biol Phys; 2022 May; 113(1):177-191. PubMed ID: 35093482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography appearance of early radiation injury to the lung: correlation with clinical and dosimetric factors.
    Jenkins P; Welsh A
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):97-103. PubMed ID: 21543163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis.
    Anscher MS; Kong FM; Andrews K; Clough R; Marks LB; Bentel G; Jirtle RL
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1029-35. PubMed ID: 9719112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
    Niibe Y; Hayakawa K; Masuda N; Yoshimura H
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
    Mehta V
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):5-24. PubMed ID: 15963660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma.
    Monson JM; Stark P; Reilly JJ; Sugarbaker DJ; Strauss GM; Swanson SJ; Decamp MM; Mentzer SJ; Baldini EH
    Cancer; 1998 Mar; 82(5):842-50. PubMed ID: 9486572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of Liangxue Jiedu Huoxue Decoction in prevention of radiation pneumonitis: a randomized controlled trial].
    Xiao C; Ding HJ; Feng LC; Qu BL; Dou YQ
    Zhong Xi Yi Jie He Xue Bao; 2010 Jul; 8(7):624-8. PubMed ID: 20619137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
    Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
    Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
    Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis.
    Anscher MS; Murase T; Prescott DM; Marks LB; Reisenbichler H; Bentel GC; Spencer D; Sherouse G; Jirtle RL
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):671-6. PubMed ID: 7928499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.
    Sio TT; Atherton PJ; Pederson LD; Zhen WK; Mutter RW; Garces YI; Ma DJ; Leenstra JL; Rwigema JM; Dakhil S; Bearden JD; van der Veen SJ; Ganti AK; Schild SE; Miller RC
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):686-696. PubMed ID: 30395904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation.
    Wurstbauer K; Deutschmann H; Kranzinger M; Merz F; Rahim H; Sedlmayer F; Kogelnik HD
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):333-41. PubMed ID: 10760428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.